Case Study

Virus Reduction Of An Affinity Capture Step - Viral Clearance For Protein A

Source: Cytiva
Viral

Challenge

Delivering safe drugs is critical for biomanufacturers. Evaluating how much a process step contributes to viral clearance is therefore an essential part of process validation. For this reason, there is an industry need to perform effective viral clearance studies.

Scope of the viral clearance case study

In this study, the virus reduction of an affinity capture step was evaluated in a scale-down column format. The study was performed by a third-party viral testing laboratory in collaboration with a biopharmaceutical company.

Outcomes

  • A robust process providing expected virus removal for different sample loads and residence times.
  • Reduction factors were in the typical range for a protein A affinity chromatography step.
  • The chromatography column format was well-suited for the viral clearance study.

Learn more about how HiScale 10/40, packed with MabSelect PrismA, is a reliable choice for the capture step in a virus clearance study.

VIEW THE CASE STUDY!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Cell & Gene? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: